Family Medicine Workshop Course 1 Materials – Ohio Academy of Family Physicians

Thank you for participating in the 2024 Family Medicine Workshop! Below you will find speaker presentations (in both a standard and condensed slide format) and additional materials to enhance your Workshop experience. Please contact Caitlin Laudeman with any questions regarding the materials.

CME Disclosure Statements

OAFP Family Medicine Workshop Planning Committee
None of the content controllers for this activity have any relevant financial relationships to disclose with ineligible companies.

Faculty
Drs. George Ho, Vivek Nadkarni, Anita Somani, and Ms. Staci Swenson have no relevant financial relationship(s) with ineligible companies to disclose.

Dr. Javier Morales has relevant financial relationship(s) with ineligible companies to disclose. Dr. Morales has been a consultant and speaker for Bayer HealthCare Pharmaceuticals Inc; Boehringer Ingelheim Pharmaceuticals, Inc.; Lilly; Novo Nordisk, Inc.; and has been a speaker for Amgen Inc. and Abbott. All relevant financial relationships have been mitigated.

Schedule of Events & Presentations

Saturday, January 13
11:00 a.m. – Noon	Welcome Reception & Exhibitor Visits
Noon – 2:30 p.m.	Urology (one slide \| three slides) Speaker: George Ho, MD – OhioHealth Physician Group Urology – Columbus, OH Learning Objectives: Understand updated American Urological Association’s (AUA) guidelines on management of hematuria Management of voiding symptoms and urinary incontinence in men and women Understand updated National Comprehensive Cancer Network and AUA guidelines on use of PSA Management and prevention of kidney stones.
2:30 – 2:45 p.m.	Break & Exhibitor Visits
2:45 – 5:15 p.m.	Renal (one slide \| three slides) Speaker: Vivek Nadkarni, MD – North Coast Nephrology – Elyria, OH Learning Objectives: Have a better understanding of CKD, specifically the importance of proteinuria Be able to explain when to use the different agents for CKD, including, Metformin, SGLT2 inhibitors, GLP1RA, and non-steroidal mineralocorticoid antagonists Learn when to refer and what can be accomplished by nephrology referral.
5:15 – 6:15 p.m.	Dinner & Exhibitor Visits
6:15 – 9:00 p.m.	Behavioral Medicine: “You Epigenetics’ed Me!” – A Case Presentation of an Adverse Childhood Experiences (ACES) Baby (one slide \| three slides) Speaker: Staci Swenson, MA, MSW, LISW-S – Director of CCBHC, Southeast Healthcare – Columbus – Columbus, OH Learning Objectives: Describe the importance of understanding ACEs and complex childhood trauma as an influencer in the development of complex and chronic health conditions Identify the five Guiding Principles of Trauma-Informed Care Formulate a trauma-informed approach to one patient’s complex case Explore and predict possible prognoses and outcomes based on patient engagement, social determinants of health, and care coordination resources.
9:00 – 10:00 p.m.	Networking Reception
Sunday, January 14
8:00 – 8:30 a.m.	Continental Breakfast
8:30 – 11:00 a.m.	OB/GYN (one slide \| three slides) Speaker: Anita Somani, MD – OhioHealth Physician Group, Gynecology – Columbus, OH Learning Objectives: Understand the current management for menopausal symptoms and options for treating patients with contraindications to traditional hormone therapy Diagnose and manage polycystic ovarian syndrome and its symptoms along with options for improving fertility in these patients Understand the management of pelvic pain from diagnosis to medication to surgical therapy Discuss the latest options for management of fibroids from medication to surgery.
11:00 – 11:15 a.m.	Break
11:15 a.m. – 12:15 p.m.	Cases in the Community: Optimizing Treatment & Considering Weight Management as a Primary Goal in People with Type 2 Diabetes (one slide \| three slides) Speaker: Javier Morales, MD, FACP, FACE, Clinical Associate Professor of Medicine, Donald and Barbara Zucker School of Medicine, Hofstra Northwell Hempstead, Vice President, Advanced Internal Medicine Group, PC – East Hills, NY Type 2 diabetes mellitus (T2DM) is a progressive disease that is largely preventable and entirely treatable. To improve long-term health outcomes, timely intensification of therapy is a foundational principle of contemporary management of people with type 2 diabetes mellitus (PwT2DM). Weight loss can significantly improve outcomes, and current guidelines recommend PwT2DM achieve and maintain weight loss to reduce the risk of serious complications. How can healthcare professionals effectively intensify treatment and communicate the significance of modest weight loss to PwT2DM and overweight/obesity? Learning Objectives: Apply current evidence-based guideline recommendations that prioritize weight loss as a treatment target in PwT2DM Intensify treatment in a timely manner consistent with current guideline recommendations and clinical evidence to help PwT2DM achieve personalized glycemic and weight loss goals Utilize shared decision-making to develop individualized management plans for PwT2DM and overweight/obesity that considers personal preferences, needs, and goals. This activity is supported through an educational grant from PeerView Institute for Medical Education (PVI). PVI received an educational grant from Lilly to support this program.